[STUDIES ON A NEW ANTITUMOR ANTIBIOTIC, TA-435 A. II. ANTITUMOR ACTIVITY OF TA-435 A].
D000818:Animals; D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D001772:Blood Cell Count; D002286:Carcinoma, Ehrlich Tumor; D002374:Catalase; D007938:Leukemia; D007942:Leukemia, Experimental; D008660:Metabolism; D051379:Mice; D009369:Neoplasms; D010336:Pathology; D010600:Pharmacology; D012106:Research; D012509:Sarcoma; D012513:Sarcoma, Experimental; D013302:Streptomyces
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D002374:Catalase
ANTIBIOTICS; ANTINEOPLASTIC AGENTS; BLOOD CELL COUNT; CARCINOMA, EHRLICH TUMOR; CATALASE; EXPERIMENTAL LAB STUDY; LEUKEMIA, EXPERIMENTAL; METABOLISM; MICE; PATHOLOGY; PHARMACOLOGY; SARCOMA, EXPERIMENTAL; STREPTOMYCES